Lifang & Partners
lifanglaw.comlifanglaw.comClient SatisfactionLawyers
Li WU
- Phone+861064096099
- Email[email protected]
Work Department
Intellectual Property
Position
Senior Partner
Career
- Represents Amgen in a series of drug patent linkage actions against generic companies before Beijing IP Court and the CNIPA.
- Represented SHARP in the case OPPO vs. SHARP in the FRAND rate disputes concerning 4G LTE SEPs before the Shenzhen Intermediate Court.
- Represented AstraZeneca in defending its pharmaceutical compound patent concerning its blockbuster drug Ticagrelor before the Beijing High Court and successfully overturned the invalidation decision made by the Patent Re-examination Board; represent AstraZeneca in the retrial case concerning this patent raised by the Patent Re-examination Board.
- Represented AstraZeneca in a series of patent validity litigations and infringement litigations concerning its blockbuster drug Ticagrelor.
- Represented Edan, a public Chinese medical device company, in a series of infringement litigations and trade secret misappropriation cases brought up by the giant medical device company Mindray and successfully settled the cases for the client.
- Represented Nichia Corporation in a series of patent litigations against a Taiwan company Everlight Electronic before the Beijing IP Court and the Patent Re-examination Board and successfully won a completed victory for the client, and these litigations are part of a global patent war between these two LED giants in the world.
- Represented SINOPEC in a series of trade secret and patent disputes against INEOs that claimed damages over one billion RMB in total and successfully helped the client achieve a settlement.
- Represented Japanese TRP company in a series of patent validity litigations and patent infringement litigations concerning its key cylinder liner patents before the Patent Re-examination Board, Beijing IP Court and Beijing Supreme People’s Court and won satisfactory results for the client.
- Represented high tech start-ups, public companies, multinational giants, as well as research institutions, including Sinopec, Novartis, Toyota, Yazaki, Nihon Kohden, Align Technology, Nichia, Michigan University, UCSF, Chinese Academy of Science, Qinghua University, Nanjing University, in patent prosecution and re-examination matters in the fields of pharmaceuticals, life sciences, medical devices, chemical engineering, mechanics and electronic engineers, and successfully obtained and protected hundreds of patents in these fields.
Languages
Chinese/English